Skip to content

Pemivibart safe, effective for prevention of COVID-19 in immunocompromised cancer patients
Golcadomide improves first-line treatment for aggressive B-cell lymphoma
FDA grants orphan drug designation to EO2463 to treat indolent non-Hodgkin lymphoma
FDA approves pivekimab sunirine-pvzy for BPDCN
Study shows ‘encouraging’ conditioning regimen for patients with relapsed or refractory acute leukemia

Insider Reader Survey

Join SOHO

Follow Us :

Insider Podcast
Society Updates
Resources
Hem/Onc Library
- Current Issue
  - Past Issues
- Cellular Therapy
- Leukemia
  - ALL
  - AML
  - CLL
  - CML
- Lymphoma
  - ABCL
  - IBCL
  - MCL
  - TCL
- MDS
- MPN
- Multiple Myeloma
Community Oncology
- Past Sessions
Meeting News
Multimedia
- Roundtable Discussions
- Video Interviews
Subscribe

About Us

The Society of Hematologic Oncology (SOHO) was established as a non-profit corporation in 2012 with aims to promote worldwide research, education, prevention, clinical studies and optimal patient care in all aspects of hematologic malignancies and related disorders.

Join SOHO

Categories

Elias Jabbour, MD

Cellular Therapy

Elias Jabbour, MD

Leukemia

Elias Jabbour, MD

Lymphoma

Elias Jabbour, MD

Multiple Myeloma

Elias Jabbour, MD

Myelodysplastic Syndromes

Elias Jabbour, MD

Myeloproliferative Neoplasms

Contact Info

[email protected] 1.281.364.7387

Follow Us

May 31, 2026

Insider Podcast
Society Updates
Resources
Hem/Onc Library
- Current Issue
  - Past Issues
- Cellular Therapy
- Leukemia
  - ALL
  - AML
  - CLL
  - CML
- Lymphoma
  - ABCL
  - IBCL
  - MCL
  - TCL
- MDS
- MPN
- Multiple Myeloma
Community Oncology
- Past Sessions
Meeting News
Multimedia
- Roundtable Discussions
- Video Interviews
Subscribe

SOHO Insider Elias Jabbour, MD

Elias Jabbour, MD

by sohonews
October 16, 2024
0 Comments
Less than a minute
595 Views
2 years ago

Share This Post:

Facebook Twitter Pinterest Whatsapp Cloud StumbleUpon Print Share via Email

Related Post

Online news on a smart phone. Businessman reading news or article on a mobile phone screen app. Hand holding smart device. Newspaper and portal on internet. Displayed news are not reality related.

2026 ASCO, News

Pemivibart safe, effective for prevention of COVID-19 in immunocompromised cancer patients

May 30, 2026

Marc Hoffman

2026 ASCO, Lymphoma, Aggressive B-Cell Lymphomas, Meetings / Conferences

Golcadomide improves first-line treatment for aggressive B-cell lymphoma

May 29, 2026

FDA laptop

Lymphoma, Indolent B-Cell Lymphomas, Mantle Cell Lymphoma, News

FDA grants orphan drug designation to EO2463 to treat indolent non-Hodgkin lymphoma

May 28, 2026

Leukemia, News

FDA approves pivekimab sunirine-pvzy for BPDCN

May 27, 2026

Stem cell transplant

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, News

Study shows ‘encouraging’ conditioning regimen for patients with relapsed or refractory acute leukemia

May 26, 2026

keyboard

Lymphoma, Indolent B-Cell Lymphomas

No OS benefit to adding bendamustine to rituximab for marginal zone lymphoma

May 22, 2026

Top Categories

Cellular Therapy

72

Leukemia

112

Lymphoma

125

Multiple Myeloma

94

Myelodysplastic Syndromes

39

Myeloproliferative Neoplasms

22

POPULAR NEWS

The Society of Hematologic Oncology (SOHO) was established as a non-profit corporation in 2012 with aims to promote worldwide research, education, prevention, clinical studies and optimal patient care in all aspects of hematologic malignancies and related disorders.

About

About Us / Editorial Board

Advertising

Contact Us

Support SOHO

Categories

Elias Jabbour, MD

Cellular Therapy

Elias Jabbour, MD

Leukemia

Elias Jabbour, MD

Lymphoma

Elias Jabbour, MD

Multiple Myeloma

Elias Jabbour, MD

Myelodysplastic Syndromes

Elias Jabbour, MD

Myeloproliferative Neoplasms

Subscribe

Recent Posts

Online news on a smart phone. Businessman reading news or article on a mobile phone screen app. Hand holding smart device. Newspaper and portal on internet. Displayed news are not reality related.

Pemivibart safe, effective for prevention of COVID-19 in immunocompromised cancer patients

Marc Hoffman

Golcadomide improves first-line treatment for aggressive B-cell lymphoma

FDA laptop

FDA grants orphan drug designation to EO2463 to treat indolent non-Hodgkin lymphoma

Copyright © 2026 Society of Hematologic Oncology, All rights reserved.